396 related articles for article (PubMed ID: 32028670)
1. PPAR-Mediated Toxicology and Applied Pharmacology.
Xi Y; Zhang Y; Zhu S; Luo Y; Xu P; Huang Z
Cells; 2020 Feb; 9(2):. PubMed ID: 32028670
[TBL] [Abstract][Full Text] [Related]
2. Impact of Phytochemicals on PPAR Receptors: Implications for Disease Treatments.
Enayati A; Ghojoghnejad M; Roufogalis BD; Maollem SA; Sahebkar A
PPAR Res; 2022; 2022():4714914. PubMed ID: 36092543
[TBL] [Abstract][Full Text] [Related]
3. The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR).
Peraza MA; Burdick AD; Marin HE; Gonzalez FJ; Peters JM
Toxicol Sci; 2006 Apr; 90(2):269-95. PubMed ID: 16322072
[TBL] [Abstract][Full Text] [Related]
4. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
[TBL] [Abstract][Full Text] [Related]
5. [Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development].
Alemán G; Torres N; Tovar AR
Rev Invest Clin; 2004; 56(3):351-67. PubMed ID: 15612519
[TBL] [Abstract][Full Text] [Related]
6. [PPARs: physiological functions and pharmacological roles of agonists in human diseases. Note II].
Filip-Ciubotaru F; Manciuc C; Grigore C; Foia L
Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):240-7. PubMed ID: 23077903
[TBL] [Abstract][Full Text] [Related]
7. The roles of peroxisome proliferator-activated receptors in the metabolic syndrome.
Mansour M
Prog Mol Biol Transl Sci; 2014; 121():217-66. PubMed ID: 24373239
[TBL] [Abstract][Full Text] [Related]
8. PPAR modulators and PPAR pan agonists for metabolic diseases: the next generation of drugs targeting peroxisome proliferator-activated receptors?
Feldman PL; Lambert MH; Henke BR
Curr Top Med Chem; 2008; 8(9):728-49. PubMed ID: 18537685
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets.
Brown JD; Plutzky J
Circulation; 2007 Jan; 115(4):518-33. PubMed ID: 17261671
[TBL] [Abstract][Full Text] [Related]
10. Thiazolidinediones as antidiabetic agents: A critical review.
Nanjan MJ; Mohammed M; Prashantha Kumar BR; Chandrasekar MJN
Bioorg Chem; 2018 Apr; 77():548-567. PubMed ID: 29475164
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
Giaginis C; Tsantili-Kakoulidou A; Theocharis S
Fundam Clin Pharmacol; 2007 Jun; 21(3):231-44. PubMed ID: 17521292
[TBL] [Abstract][Full Text] [Related]
12. Blocking the peroxisome proliferator-activated receptor (PPAR): an overview.
Ammazzalorso A; De Filippis B; Giampietro L; Amoroso R
ChemMedChem; 2013 Oct; 8(10):1609-16. PubMed ID: 23939910
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome Proliferated Activated Receptors (PPARs): Opportunities and Challenges for Ocular Therapy.
Khatol P; Saraf S; Jain A
Crit Rev Ther Drug Carrier Syst; 2018; 35(1):65-97. PubMed ID: 29611471
[TBL] [Abstract][Full Text] [Related]
14. PPARs as Nuclear Receptors for Nutrient and Energy Metabolism.
Hong F; Pan S; Guo Y; Xu P; Zhai Y
Molecules; 2019 Jul; 24(14):. PubMed ID: 31336903
[TBL] [Abstract][Full Text] [Related]
15. Healing the diabetic heart: modulation of cardiometabolic syndrome through peroxisome proliferator activated receptors (PPARs).
Huang TH; Roufogalis BD
Curr Mol Pharmacol; 2012 Jun; 5(2):241-7. PubMed ID: 22122453
[TBL] [Abstract][Full Text] [Related]
16. The Journey of Thiazolidinediones as Modulators of PPARs for the Management of Diabetes: A Current Perspective.
Ahsan W
Curr Pharm Des; 2019; 25(23):2540-2554. PubMed ID: 31333088
[TBL] [Abstract][Full Text] [Related]
17. Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications.
Mirza AZ; Althagafi II; Shamshad H
Eur J Med Chem; 2019 Mar; 166():502-513. PubMed ID: 30739829
[TBL] [Abstract][Full Text] [Related]
18. [The role of peroxisome proliferator-activated receptors (PPAR) in carcinogenesis].
Knapp P; Jarzabek K; Błachnio A; Zbroch T
Ginekol Pol; 2006 Aug; 77(8):643-51. PubMed ID: 17076197
[TBL] [Abstract][Full Text] [Related]
19. [PPARs and heart diseases].
Takano H; Komuro I
Nihon Rinsho; 2005 Apr; 63(4):659-64. PubMed ID: 15828234
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.
Latruffe N; Vamecq J
Biochimie; 1997; 79(2-3):81-94. PubMed ID: 9209701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]